Search research articles
Contact Us
Filters
Showing results (21-30 of 236) with videos related to
Page
of 24
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
May 4, 2010
Impact of organism species on microbial eradication and development of resistance in severe gram-negative pneumonia
S Kiem, J J Schentag
The American Journal of Medicine
|
April 6, 1992
Quinolone pharmacokinetics in the elderly
J J Schentag, T F Goss
International Journal of Antimicrobial Agents
|
January 4, 2001
Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections
P A Moise, J J Schentag
Diagnostic Microbiology and Infectious Disease
|
May 1, 1995
Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics
D E Nix, J J Schentag
The Medical Clinics of North America
|
January 1, 1982
Principles of antibiotic tissue penetration and guidelines for pharmacokinetic analysis
J J Schentag, F M Gengo
Kidney International
|
May 1, 1980
Patterns of urinary beta 2-microglobulin excretion by patients treated with aminoglycosides
J J Schentag, M E Plaut
The American Journal of Medicine
|
September 12, 1991
Tissue-directed pharmacokinetics
J J Schentag, C H Ballow
American Journal of Hospital Pharmacy
|
April 1, 1993
Pharmacokinetics and pharmacodynamics of acid-suppressive agents in patients with gastroesophageal reflux disease
J J Schentag, T F Goss
Infection Control and Hospital Epidemiology
|
February 2, 2000
Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa
J M Hyatt, J J Schentag
Diagnostic Microbiology and Infectious Disease
|
February 1, 1992
Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group
C H Ballow, J J Schentag
Page
of 24
Search research articles
Search
Showing results (21-30 of 236) with videos related to
Sort By:
Page
of 24
Journal of Chemotherapy (Florence, Italy)
|
May 4, 2010
Impact of organism species on microbial eradication and development of resistance in severe gram-negative pneumonia
S Kiem, J J Schentag
The American Journal of Medicine
|
April 6, 1992
Quinolone pharmacokinetics in the elderly
J J Schentag, T F Goss
International Journal of Antimicrobial Agents
|
January 4, 2001
Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections
P A Moise, J J Schentag
Diagnostic Microbiology and Infectious Disease
|
May 1, 1995
Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics
D E Nix, J J Schentag
The Medical Clinics of North America
|
January 1, 1982
Principles of antibiotic tissue penetration and guidelines for pharmacokinetic analysis
J J Schentag, F M Gengo
Kidney International
|
May 1, 1980
Patterns of urinary beta 2-microglobulin excretion by patients treated with aminoglycosides
J J Schentag, M E Plaut
The American Journal of Medicine
|
September 12, 1991
Tissue-directed pharmacokinetics
J J Schentag, C H Ballow
American Journal of Hospital Pharmacy
|
April 1, 1993
Pharmacokinetics and pharmacodynamics of acid-suppressive agents in patients with gastroesophageal reflux disease
J J Schentag, T F Goss
Infection Control and Hospital Epidemiology
|
February 2, 2000
Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa
J M Hyatt, J J Schentag
Diagnostic Microbiology and Infectious Disease
|
February 1, 1992
Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group
C H Ballow, J J Schentag
Page
of 24